Adjuvant therapy with Astragalus membranaceus for post-stroke fatigue: a systematic review

In conclusions, adjuvant therapy with CHM-HQ may benefit in managing fatigue and quality of life in stroke patients. However, stronger evidence is needed for a promising conclusion and more rigorous designs of RCTs are merited in the future.
Source: Metabolic Brain Disease - Category: Neurology Source Type: research